PAG
CRL icon

Private Advisor Group’s Charles River Laboratories CRL Stock Holding History

Private Advisor Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,767
Closed -$348K – 2325
2024
Q3 		$348K Sell
1,767
-211
-11% -$43.9K ﹤0.01% 1841
2024
Q2 		$409K Buy
1,978
+273
+16% +$61.9K ﹤0.01% 1676
2024
Q1 		$462K Buy
1,705
+23
+1% +$5.49K ﹤0.01% 1570
2023
Q4 		$398K Buy
+1,682
New +$331K ﹤0.01% 1606
2022
Q3 		– Sell
-1,370
Closed -$293K – 1963
2022
Q2 		$293K Buy
1,370
+39
+3% +$9.53K ﹤0.01% 1658
2022
Q1 		$378K Buy
1,331
+178
+15% +$54.9K ﹤0.01% 1550
2021
Q4 		$434K Sell
1,153
-15,780
-93% -$6.13M ﹤0.01% 1518
2021
Q3 		$6.99M Buy
16,933
+7,878
+87% +$3.27M 0.04% 406
2021
Q2 		$3.35M Buy
9,055
+557
+7% +$186K 0.03% 554
2021
Q1 		$2.46M Sell
8,498
-1,143
-12% -$318K 0.02% 625
2020
Q4 		$2.41M Buy
+9,641
New +$2.3M 0.03% 600
2020
Q3 		– Sell
-256
Closed -$45K – 1929
2020
Q2 		$45K Buy
+256
New +$40.9K ﹤0.01% 2157
2017
Q2 		– Sell
-32,742
Closed -$769K – 1397
2017
Q1 		$769K Buy
+32,742
New +$2.78M 0.02% 624
2014
Q4 		– Sell
-5,567
Closed -$333K – 1041
2014
Q3 		$333K Hold
5,567
– – 0.02% 659
2014
Q2 		$298K Buy
+5,567
New +$305K 0.03% 656

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Private Advisor Group's CRL Position: Q4 2024 in Review

Private Advisor Group sold out of Charles River Laboratories (CRL) in Q4 2024, closing a stake of 1,767 shares — an estimated $348K sold.

Private Advisor Group first reported a position in CRL in Q2 2014 and held it in 15 quarters. The position peaked at $6.99M in Q3 2021. 637 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

  • Private Advisor Group reported no remaining Charles River Laboratories position as of Q4 2024 after selling out during the quarter.
  • Private Advisor Group sold 1,767 Charles River Laboratories shares in Q4 2024, an estimated $348K.
  • Private Advisor Group first reported a position in Charles River Laboratories in Q2 2014 and held it in 15 quarters.
  • Private Advisor Group's Charles River Laboratories position peaked at $6.99M in Q3 2021.
  • 637 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on Private Advisor Group's 13F filing for Q4 2024, filed 3 Feb 2025.